Holger Weis
Vermogen: 58 076 $ op 30-06-2026
Vermogen: 58 076 $ op 30-06-2026
Holger Weis is the founder of Weis Advisors, Inc., founded in 2018, serving as President & Principal.
Current jobs include Chairman & Chief Executive Officer at Alaunos Therapeutics, Inc. since 2025 and Independent Director at Jupiter Neurosciences, Inc. since 2021.
Former jobs include Chief Financial Officer & Director at Phenotarget Biosciences, Inc. from 2020 to 2021;.
Senior Manager at Ernst & Young LLP from 1986 to 2000; Chief Financial Officer & Treasurer at GMP Cos., Inc. from 2000 to 2005; President, Chief Operating & Financial Officer at DemeRx, Inc. from 2011 to 2017; Chief Financial Officer, Secretary & VP at NovaVision, Inc. from 2006 to 2010; and Chief Financial Officer at EnSA Holdings LLC from 2010 to 2011.
Education includes an undergraduate degree from the University of Georgia, conferred in 1985.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 30-06-2026 | 16.552 ( 0,68% ) | 37 408 $ | 30-06-2026 | |
| 02-06-2026 | 96.581 ( 0,2% ) | 20 668 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ALAUNOS THERAPEUTICS, INC. | Algemeen Directeur | 02-07-2025 |
| JUPITER NEUROSCIENCES, INC. | Directeur/Bestuurslid | 08-09-2021 |
Weis Advisors, Inc. | Oprichter | 01-04-2018 |
| Bedrijven | Functie | Einde |
|---|---|---|
Phenotarget Biosciences, Inc.
Phenotarget Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Financieel Directeur/CFO | 01-03-2021 |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | President | 24-07-2017 |
EnSA Holdings LLC
EnSA Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides business of agricultural production and development consulting in the Dominican Republic | Financieel Directeur/CFO | 01-11-2011 |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Financieel Directeur/CFO | 01-08-2010 |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Financieel Directeur/CFO | 01-01-2005 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 10 |
|---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Provides assurance, auditing, tax, legal, technology and consulting & managed services | Commercial Services |
GMP Cos., Inc.
GMP Cos., Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals, diagnostic products, and medical devices | Health Technology |
DemeRx, Inc.
DemeRx, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
NovaVision, Inc.
NovaVision, Inc. Medical/Nursing ServicesHealth Services Provides vision restoration therapy services | Health Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alaunos Therapeutics, Inc.
Alaunos Therapeutics, Inc. BiotechnologyHealth Technology Develops a portfolio of immuno-oncology therapies | Health Technology |
EnSA Holdings LLC
EnSA Holdings LLC Miscellaneous Commercial ServicesCommercial Services Provides business of agricultural production and development consulting in the Dominican Republic | Commercial Services |
Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Weis Advisors, Inc. | |
Phenotarget Biosciences, Inc.
Phenotarget Biosciences, Inc. Medical/Nursing ServicesHealth Services Provides health care services | Health Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau